Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program - Colorado Bioscience Association

This topic has 0 replies, 1 voice, and was last updated 4 years, 5 months ago by Colorado BioScience Association.

Viewing 1 post (of 1 total)

Author

Posts
05/06/2020 at 9:54 am #4905

Colorado BioScience Association
Keymaster

First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine.

Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021

Find out more.
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.